These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18693629)

  • 1. [Adrenocortical carcinoma].
    Gur C; Salmon A; Silvetski N; Gross DJ
    Harefuah; 2008 Jun; 147(6):520-5, 574. PubMed ID: 18693629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocortical tumors in children.
    Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
    J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocortical carcinoma: epidemiology and natural history.
    Boscaro M; Fallo F; Barzon L; Daniele O; Sonino N
    Minerva Endocrinol; 1995 Mar; 20(1):89-94. PubMed ID: 7651287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenocortical carcinoma.
    van Ditzhuijsen CI; van de Weijer R; Haak HR
    Neth J Med; 2007 Feb; 65(2):55-60. PubMed ID: 17379929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotane treatment for adrenocortical carcinoma: an overview.
    De Francia S; Ardito A; Daffara F; Zaggia B; Germano A; Berruti A; Di Carlo F
    Minerva Endocrinol; 2012 Mar; 37(1):9-23. PubMed ID: 22382612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocortical carcinoma -- improving patient care by establishing new structures.
    Koschker AC; Fassnacht M; Hahner S; Weismann D; Allolio B
    Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):45-51. PubMed ID: 16570232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical carcinoma.
    Rodgers SE; Evans DB; Lee JE; Perrier ND
    Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical aspects in the treatment of adrenocortical carcinomas in children: data of the GPOH-MET 97 trial.
    Hubertus J; Boxberger N; Redlich A; von Schweinitz D; Vorwerk P
    Klin Padiatr; 2012 Apr; 224(3):143-7. PubMed ID: 22504769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and therapy of hormonally active cancer of the adrenal cortex. Study of 5 cases].
    Tenschert W; Vetter H; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1981 Jul; 111(29):1080-8. PubMed ID: 7268361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review.
    Advani A; Vaikkakara S; Gill MS; Arun CS; Pearce SH; Ball SG; James RA; Lennard TW; Bliss RD; Quinton R; Johnson SJ
    J Clin Pathol; 2008 Aug; 61(8):939-44. PubMed ID: 18515402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.
    Luton JP; Cerdas S; Billaud L; Thomas G; Guilhaume B; Bertagna X; Laudat MH; Louvel A; Chapuis Y; Blondeau P
    N Engl J Med; 1990 Apr; 322(17):1195-201. PubMed ID: 2325710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatment of adrenocortical carcinoma in children: data from the German GPOH-MET 97 trial.
    Redlich A; Boxberger N; Strugala D; Frühwald MC; Leuschner I; Kropf S; Bucsky P; Vorwerk P
    Klin Padiatr; 2012 Oct; 224(6):366-71. PubMed ID: 23143764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol as a possible marker of metastatic adrenocortical carcinoma: a case report with 3-year follow-up.
    Schwarte S; Brabant EG; Bastian L; Bruns F
    Anticancer Res; 2007; 27(4A):1917-20. PubMed ID: 17649795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma.
    Gonzalez RJ; Tamm EP; Ng C; Phan AT; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE
    Surgery; 2007 Dec; 142(6):867-75; discussion 867-75. PubMed ID: 18063070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carcinoma of the adrenal cortex].
    Hamborg B; Frey H; Bøhmer T; Norman N
    Tidsskr Nor Laegeforen; 1990 Mar; 110(8):956-9. PubMed ID: 2321225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive treatment of adrenocortical carcinoma.
    Terzolo M; Berruti A
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):221-6. PubMed ID: 18438168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant mitotane in adrenocortical carcinoma.
    Dickstein G; Shechner C; Nativ O
    N Engl J Med; 2007 Sep; 357(12):1257-8; author reply 1259. PubMed ID: 17891838
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenocortical cancer: pathophysiology and clinical management.
    Libè R; Fratticci A; Bertherat J
    Endocr Relat Cancer; 2007 Mar; 14(1):13-28. PubMed ID: 17395972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocortical carcinoma: clinical and laboratory observations.
    Wajchenberg BL; Albergaria Pereira MA; Medonca BB; Latronico AC; Campos Carneiro P; Alves VA; Zerbini MC; Liberman B; Carlos Gomes G; Kirschner MA
    Cancer; 2000 Feb; 88(4):711-36. PubMed ID: 10679640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functioning and nonfunctioning adrenocortical carcinoma: clinical presentation and therapeutic strategies.
    Demeure MJ; Somberg LB
    Surg Oncol Clin N Am; 1998 Oct; 7(4):791-805. PubMed ID: 9735134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.